Boston Micro Fabrication (BMF) has achieved a significant milestone in the realm of cosmetic dentistry with the receipt of FDA 510(k) clearance for its innovative UltraThineer material. This clearance marks a groundbreaking advancement in dental technology, offering a new solution for creating ultra-thin cosmetic dental veneers.
The UltraThineer material, developed by BMF, is set to revolutionize the field of cosmetic dentistry. Utilizing projection micro stereolithography (PµSL) technology, these veneers are crafted with exceptional precision, resulting in a level of detail and accuracy that is three times higher than that of traditional veneers.
One of the key advantages of UltraThineer veneers is their minimal preparation requirement. Dental professionals will need to perform significantly less preparation compared to traditional veneers, preserving more of the patient’s original enamel. This not only reduces the invasiveness of the procedure but also ensures a more natural and aesthetically pleasing final result.
Dany Karam, President of Advanced Dental Technologies, expressed excitement about the FDA clearance, highlighting the potential impact of UltraThineer veneers on the dental industry. “This clearance is a significant milestone for our industry,” said Karam. “The ability to 3D print veneers in Zirconia represents a major advancement in dental technology, offering patients high-quality veneers with minimal preparation.”
UltraThineer veneers are not only thinner but also feature advanced materials and production workflows, delivering superior comfort and aesthetics. Developed in collaboration with Peking University, these veneers set a new standard of excellence in cosmetic dentistry.
Professor Sun Yuchun from Peking University School of Stomatology praised the durability and aesthetic improvements offered by UltraThineer veneers. “With minimized tooth reduction and enhanced appearance, these veneers represent a significant advancement in cosmetic dentistry,” said Professor Yuchun.
BMF has already begun partnering with dental labs across the U.S. to make UltraThineer commercially available. Patients can expect to have access to this innovative treatment option in the second half of 2024.
John Kawola, CEO-Global at BMF, emphasized the company’s commitment to innovation and expanding options in cosmetic dentistry. “We believe that UltraThineer veneers have the potential to revolutionize the field of cosmetic dentistry,” said Kawola. “With their exceptional precision and minimal invasiveness, UltraThineer veneers offer patients a highly aesthetic solution for enhancing their smiles.”
With the FDA clearance for UltraThineer veneers, BMF has solidified its position as a leader in advanced manufacturing solutions for the dental industry. The future of cosmetic dentistry looks brighter than ever, thanks to the innovative technology and groundbreaking materials developed by BMF.
